ROCKVILLE, MD - (27 November, 2001) - Shire Laboratories, Inc. announced today that the US Patent and Trademark Office has issued US Patent # 6,322,819 for the company's oral pulsed dose drug delivery system.

# # #

   THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties, including but not limited to, risks associated with the inherent uncertainty of pharmaceutical research, product development and commercialization, the impact of competitive products, patents, and other risks and uncertainties, including those detailed from time to time in periodic reports, including the F-4 Prospectus and the Annual Report filed on Form 20-F with the Securities and Exchange Commission.